NIKKEI 225
33,438.16 +116.94 (+0.35%) HANG SENG
16,974.36 -19.08 (-0.11%) CRUDE OIL
78.06 +0.20 (+0.26%) GOLD FUTURES
2,062.60 -4.50 (-0.22%) DOW
35,430.42 +13.44 (+0.04%) Bitcoin GBP
29,887.94 +4.48 (+0.01%)
Evotec SE (0IRF.IL)
- Insider Monkey
Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript
Evotec SE (NASDAQ:EVO) Q3 2023 Earnings Call Transcript November 11, 2023 Werner Lanthaler: Welcome to our — good morning. Good afternoon. Welcome to our Q3 Call. Resilient into the Future of Biopharma R&D. That’s how we titled this presentation, which we have uploaded to the Internet and you are welcome to join this call also […]
- GlobeNewswire
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
PARTNERSHIP TO ACCELERATE DEWPOINT’S LEADING ONCOLOGY PIPELINE PROGRAMS TO INVESTIGATIONAL NEW DRUG APPLICATIONS COLLABORATION LEVERAGES EVOTEC’S FULLY INTEGRATED, CLINICAL-ENABLING INDIGO CAPABILITY PLATFORMAGREEMENT IS BASED ON A RISK-SHARING ARRANGEMENT FOLLOWED BY MILESTONE AND ROYALTY PAYMENTS TO EVOTEC BASED ON SUCCESS OF OVERALL PROGRAMS HAMBURG, Germany and BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) an
- Simply Wall St.
Further weakness as Evotec (ETR:EVT) drops 6.5% this week, taking three-year losses to 23%
Many investors define successful investing as beating the market average over the long term. But in any portfolio...
